Parallel for IBS receives CE mark

Irritable bowel syndrome (IBS) is a disorder of the gut-brain interaciont. Parallel, which is a prescription-only digital theraputic (PDT), helps patients change certain behaviours that contributes to IBS and has been clinically proven to reduce the severity of IBS symptoms. Check out the article here: Digital therapeutic for IBS receives CE mark – Med-Tech Innovation …

Parallel for IBS receives CE mark Read More »

Current vaccines are less effective against COVID-19 variants

According to a study about SARS-CoV-2 in the U.K and South Africa states that current vaccines and treatments  against the virus may be less effective at neutralizing the new variants.   Check out the article here: Current vaccines and therapies may be less effective at neutralizing new SARS-CoV-2 variants (news-medical.net)

New ingredient against Parkinson’s disease

Researchers have discovered that a chemical from sesame seed oil, called sesaminoal, has protective effects against Parkinson’s disease. Check the article out in the following link: Researchers discover new ingredient that has protective effects against Parkinson’s disease (news-medical.net)

New UK Medical Device Legislation

The UK has updated regulations on medical devices and other health products after the Brexit. This new legislation supports databases, information flows and sactions related to medical devices.   UK adopts medical device legislation, setting stage for new databases and sanctions | MedTech Dive

Adaptive therapy for cancer

This month’s in Cancer Research an article reports the results of a study using mathematical models to show that cell turnover affects drug resistance, which is an important factor driving the success of adaptive therapy. Mathematical model reveals how cell turnover determines the success of adaptive therapy (news-medical.net)